Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques
International Journal of Molecular Sciences · 23.02.2024 · 25 (5) · 2591
DOI: 10.3390/ijms25052591 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.02.2024. Verfasst von Aleksandra Liana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, Żwirki i Wigury 101, 02-089 Warsaw, Poland. Hauptthemen laut MEDLINE: Linagliptin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of Poland, University of Warsaw.
Abstract (Originalsprache)
As part of the development and production of pharmaceuticals, the purity of Active Pharmaceutical Ingredients stands as a fundamental parameter that significantly influences the quality, safety, and efficacy of the final drug product. Impurities in Active Pharmaceutical Ingredients are various unwanted substances that can appear during the whole manufacturing process, from raw materials to the final product. These impurities can stem from multiple sources, including starting materials, intermediates, reagents, solvents, and even degradation products resulting from exposure to environmental factors such as heat, light, or moisture. Their presence can potentially compromise the therapeutic effect of the drug, introduce unexpected side effects, or even pose safety risks to patients. This study aims to conduct the forced degradation of linagliptin and subsequently attempt to identify the resulting degradants. The degradation procedures were carried out in accordance with the guidelines of the International Committee for Harmonization. The degradation profile of linagliptin was investigated under various conditions, including acid hydrolysis, alkaline hydrolysis, oxidation, heat, and light exposure, utilizing ultra-performance liquid chromatography connected to a photo array detector. Identification and characterization of the degradation products were achieved using an ultra-performance liquid chromatography coupled with a single quadrupole detector mass spectrometer and also a liquid chromatography coupled with a high-resolution mass spectrometry. The identified degradation products demonstrate that linagliptin is particularly susceptible to degradation when exposed to acid and peroxide. Whereas, no significant degradation effects were observed under alkali, thermolytic, and photolytic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, Żwirki i Wigury 101, 02-089 Warsaw, Poland.
- Pharmaceutical Plant Polpharma S.A., Pelpińska 19, 83-200 Starograd Gdański, Poland.
- Faculty of Chemistry, Gdańsk University of Technology, Gabriela Narutowicza 11/12, 80-233 Gdańsk, Poland.
ORCID-Profile: Andrzej Gawor, Ewa Bulska
Förderung
- Ministry of Science and Higher Education of Poland
- University of Warsaw
Zitieren
APA
Liana, A., Hałuszczuk, A., Gawor, A., & Bulska, E. (2024). Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques. International Journal of Molecular Sciences, 25(5), 2591. https://doi.org/10.3390/ijms25052591
Vancouver
Liana A, Hałuszczuk A, Gawor A, Bulska E. Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques. International Journal of Molecular Sciences. 2024;25(5):2591. doi:10.3390/ijms25052591
BibTeX
@article{Liana2024,
author = {Liana, Aleksandra and Hałuszczuk, Adam and Gawor, Andrzej and Bulska, Ewa},
title = {Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {5},
pages = {2591},
doi = {10.3390/ijms25052591}
}
EUVIMED